Understanding the Legal and Ethical Challenges AI Poses in Oncology
The field of oncology is undergoing a transformation, driven by the rapid integration of artificial intelligence (AI) technology. These advancements promise unprecedented improvements in cancer detection, personalized treatment strategies, and patient support. However, as the integration of AI into oncology progresses, a myriad of legal and ethical challenges emerges.
AI in Diagnosis and Treatment
AI tools have been instrumental in enhancing the analysis of medical imaging data, such as MRI scans, CT scans, and mammograms. These algorithms are adept at identifying subtle patterns that might elude human observation, potentially leading to faster and more accurate cancer detection. AI also plays a crucial role in treatment delivery and decision-making, particularly in radiation therapy and immunotherapy regimen design.
Yet, the use of AI in diagnosis raises significant legal questions. Traditionally, human physicians are not held strictly liable for incorrect diagnoses or treatments if their conduct meets the standard of care. However, defining a legal standard for AI-related errors remains uncertain. Some propose a strict liability standard, holding manufacturers accountable for defects without needing to prove fault, while others suggest alternative product liability standards.
Legal Standards and Liability
The complexity of applying legal standards to AI tools is compounded by their evolving nature. AI algorithms often change as they process more data, challenging traditional product liability frameworks. Different jurisdictions are adopting varied approaches to liability, with the European Commission discussing a proposed AI Liability Directive for high-risk AI systems.
Patient Counseling and Ethical Considerations
Beyond diagnostics, AI is also being explored for patient counseling. Studies have evaluated the use of AI chatbots for cancer-related inquiries, with mixed results. While these chatbots can provide helpful information, they are not yet fully ready for patient-facing roles. A recent study found that AI chatbots were as effective as human counselors in educating breast cancer patients about genetic dimensions, suggesting potential in freeing up human resources for more intensive counseling.
However, using AI in patient counseling introduces critical ethical issues, particularly regarding data security and informed consent. Patients must be aware they are receiving advice from an AI system, and there must be safeguards against harmful advice.
Future Directions and Challenges
The integration of AI into oncology presents long-term challenges, including ensuring that AI enhances rather than diminishes professional skills. Oncology professionals must be trained to effectively use AI tools, much like adapting to electronic medical records in previous eras.
In conclusion, while AI offers promising advancements in oncology, its legal and ethical implications are evolving and uncertain. Understanding these complexities is crucial to ensuring that AI serves as a tool to augment human expertise and improve patient outcomes. For more details, refer to the original article on The ASCO Post.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Long Island’s commercial real estate market just smashed every previous record, hitting an unprecedented $4.1 billion in 2025 deal volume—up a massive 71.5 percent from the year before. A surge in specialty-use properties like assisted living centers and self-storage facilities fueled the boom, alongside hundreds of new transactions across Nassau and Suffolk counties. With investor confidence rebounding, interest rates easing, and new buyer profiles entering the scene, the region has become one of the hottest real estate markets to watch.
Federal cuts to housing oversight in 2026 are creating a nationwide regulatory scramble, with states—especially California—rapidly stepping in to fill the gap. As the CFPB reduces its enforcement role, lawmakers and agencies across the country are crafting their own rules on mortgage compliance, consumer protection, affordability, and even AI‑driven underwriting. For real estate, mortgage, and finance professionals, the message is clear: state regulations are becoming just as influential as federal policy, making ongoing education and compliance awareness more critical than ever.
The insurance industry poured an eye‑opening $172 million into federal lobbying in 2025, making it the fourth‑largest lobbying sector in the country. Medical insurers led the spending, but property and casualty giants weren’t far behind, with APCIA, Nationwide, Liberty Mutual, and Allstate all landing among the top contributors. And this is only federal spending—state‑level influence, where regulations are truly shaped, remains vastly underreported. For professionals in insurance, real estate, and finance, these lobbying efforts play a powerful role in shaping regulations, costs, and the competitive landscape.
Florida’s home insurance market saw a 3.35% non-renewal rate last year—a small percentage that translated into hundreds of thousands of homeowners suddenly losing coverage. Driven by repeated storm damage, soaring construction costs, heavy litigation, and insurers pulling back from high-risk areas, the state’s insurance landscape is rapidly shifting. Homeowners now face higher premiums, fewer options, and tougher underwriting, while professionals in real estate, mortgage, and insurance must stay informed to guide clients through a tightening market.
Florida’s recent tort reforms are doing far more than reshaping the state’s legal system—they’re driving down property and casualty insurance costs by an average of 14.5% and injecting over $4.2 billion into the state’s economy each year. With nearly 30,000 jobs supported and state and local governments seeing hundreds of millions in new tax revenue, the changes are already transforming Florida’s insurance market. Lawsuits have dropped, insurers are returning, and businesses and homeowners alike are reaping the benefits of a more balanced, competitive, and financially resilient environment.
Major commercial real estate firms are reporting strong revenue and renewed market activity, signaling a rebound in dealmaking and office demand. Yet even with record earnings, CEOs from CBRE, Colliers, and Marcus & Millichap spent much of their earnings calls addressing a growing concern: whether artificial intelligence could threaten traditional brokerage and valuation roles. While leaders insist that complex transactions still rely on human relationships and negotiation, AI‑related market jitters briefly pushed some CRE stocks down before they recovered.
Legal Standards and Liability
The complexity of applying legal standards to AI tools is compounded by their evolving nature. AI algorithms often change as they process more data, challenging traditional product liability frameworks. Different jurisdictions are adopting varied approaches to liability, with the European Commission discussing a proposed 
